BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34514574)

  • 1. What Would Next Generation Sequencing Bring to the Diagnosis and Treatment of Sarcomas? A Series of 20 Cases, a Single Institution's Experience.
    Kulaç İ; Bulutay P; Meriçöz ÇA
    Turk Patoloji Derg; 2021; 37(3):226-232. PubMed ID: 34514574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Next-Generation Sequencing as a Diagnostic Tool for the Evaluation of Bone and Soft-Tissue Tumors.
    Szurian K; Kashofer K; Liegl-Atzwanger B
    Pathobiology; 2017; 84(6):323-338. PubMed ID: 28817827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular pathology of soft tissue tumors: Contribution to diagnosis and therapy prediction].
    Schmitz K; Schildhaus HU
    Pathologe; 2015 Mar; 36(2):126-36. PubMed ID: 25822596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of sarcoma fusions by a next-generation sequencing based-ligation-dependent multiplex RT-PCR assay.
    Lanic MD; Le Loarer F; Rainville V; Sater V; Viennot M; Beaussire L; Viailly PJ; Angot E; Hostein I; Jardin F; Ruminy P; Laé M
    Mod Pathol; 2022 May; 35(5):649-663. PubMed ID: 35075283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone and soft tissue tumors: clinicoradiologic-pathologic molecular-genetic correlation of novel fusion spindled, targetable-ovoid, giant-cell-rich, and round cell sarcomas.
    Fanburg-Smith JC; Smith JD; Flemming DJ
    Skeletal Radiol; 2023 Mar; 52(3):517-540. PubMed ID: 36542130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The necessity and urgency of molecular analysis in the diagnosis and treatment of bone and soft tissue sarcomas].
    Niu XH; Xu HR
    Zhonghua Yi Xue Za Zhi; 2022 Aug; 102(31):2399-2404. PubMed ID: 36000368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma.
    Zhu G; Benayed R; Ho C; Mullaney K; Sukhadia P; Rios K; Berry R; Rubin BP; Nafa K; Wang L; Klimstra DS; Ladanyi M; Hameed MR
    Mod Pathol; 2019 May; 32(5):609-620. PubMed ID: 30459475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the Molecular Analysis of Soft Tissue Tumors and Clinical Implications.
    Marino-Enriquez A
    Surg Pathol Clin; 2015 Sep; 8(3):525-37. PubMed ID: 26297069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss.
    Lazo de la Vega L; Hovelson DH; Cani AK; Liu CJ; McHugh JB; Lucas DR; Thomas DG; Patel RM; Tomlins SA
    Hum Pathol; 2016 Dec; 58():161-170. PubMed ID: 27664537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary Sarcoma Diagnosis, Genetics, and Genomics.
    Schaefer IM; Cote GM; Hornick JL
    J Clin Oncol; 2018 Jan; 36(2):101-110. PubMed ID: 29220288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence in Situ Hybridization (FISH) for Differential Diagnosis of Soft Tissue Sarcomas.
    Asif A; Mushtaq S; Hassan U; Akhtar N; Hussain M; Azam M; Qazi R
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):655-660. PubMed ID: 29580035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases.
    Xu B; Suurmeijer AJH; Agaram NP; Zhang L; Antonescu CR
    Histopathology; 2021 Sep; 79(3):347-357. PubMed ID: 33382123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation.
    Le Loarer F; Cleven AHG; Bouvier C; Castex MP; Romagosa C; Moreau A; Salas S; Bonhomme B; Gomez-Brouchet A; Laurent C; Le Guellec S; Audard V; Giraud A; Ramos-Oliver I; Cleton-Jansen AM; Savci-Heijink DC; Kroon HM; Baud J; Pissaloux D; Pierron G; Sherwood A; Coindre JM; Bovée JVMG; Larousserie F; Tirode F
    Mod Pathol; 2020 Mar; 33(3):404-419. PubMed ID: 31383960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel and established EWSR1 gene fusions and associations identified by next-generation sequencing and fluorescence in-situ hybridization.
    Krystel-Whittemore M; Taylor MS; Rivera M; Lennerz JK; Le LP; Dias-Santagata D; Iafrate AJ; Deshpande V; Chebib I; Nielsen GP; Wu CL; Nardi V
    Hum Pathol; 2019 Nov; 93():65-73. PubMed ID: 31430493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of fluorescence in situ hybridization in the diagnosis of 230 mesenchymal neoplasms: an institutional experience.
    Tanas MR; Rubin BP; Tubbs RR; Billings SD; Downs-Kelly E; Goldblum JR
    Arch Pathol Lab Med; 2010 Dec; 134(12):1797-803. PubMed ID: 21128778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions.
    Brčić I; Godschachner TM; Bergovec M; Igrec J; Till H; Lackner H; Scheipl S; Kashofer K; Brodowicz T; Leithner A; Szkandera J; Liegl-Atzwanger B
    Mod Pathol; 2021 Feb; 34(2):396-407. PubMed ID: 32860002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions.
    Schöpf J; Uhrig S; Heilig CE; Lee KS; Walther T; Carazzato A; Dobberkau AM; Weichenhan D; Plass C; Hartmann M; Diwan GD; Carrero ZI; Ball CR; Hohl T; Kindler T; Rudolph-Hähnel P; Helm D; Schneider M; Nilsson A; Øra I; Imle R; Banito A; Russell RB; Jones BC; Lipka DB; Glimm H; Hübschmann D; Hartmann W; Fröhling S; Scholl C
    Nat Commun; 2024 Jan; 15(1):51. PubMed ID: 38168093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ChildSeq-RNA: A next-generation sequencing-based diagnostic assay to identify known fusion transcripts in childhood sarcomas.
    Qadir MA; Zhan SH; Kwok B; Bruestle J; Drees B; Popescu OE; Sorensen PH
    J Mol Diagn; 2014 May; 16(3):361-70. PubMed ID: 24517889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical application of RNA sequencing in sarcoma diagnosis: An institutional experience.
    Pei J; Zhao X; Patchefsky AS; Flieder DB; Talarchek JN; Testa JR; Wei S
    Medicine (Baltimore); 2019 Jun; 98(25):e16031. PubMed ID: 31232935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of fusion transcripts in sarcoma from archival formalin-fixed paraffin-embedded tissues: A next-generation sequencing approach.
    Fujii T; Takeda M; Uchiyama T; Nitta Y; Maebou K; Terada C; Okada F; Matsuoka M; Sugimoto S; Sasaki S; Morita K; Itami H; Miyake M; Takeda M; Sawabata N; Fujimoto K; Ohbayashi C
    Pathol Int; 2022 Sep; 72(9):444-456. PubMed ID: 35975909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.